Neutralization activity of sera/IgG preparations from fully BNT162b2 vaccinated individuals against SARS-CoV-2 Alpha, Beta, Gamma, Delta, and Kappa variants

In the present prospective study, 225 individuals in Kumamoto General Hospital, Japan, who received two-doses of BNT162b2 vaccine were enrolled/followed up over 150 days and neutralizing activity (NT(50)) of their sera and antiviral activity (EC(50)) of IgG purified from sera on day-60 post-1st-dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Amano, Masayuki, Otsu, Sachiko, Maeda, Kenji, Uemura, Yukari, Shimizu, Yosuke, Omata, Kazumi, Matsuoka, Masao, Shimada, Shinya, Mitsuya, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358380/
https://www.ncbi.nlm.nih.gov/pubmed/35941265
http://dx.doi.org/10.1038/s41598-022-17071-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358380/
https://www.ncbi.nlm.nih.gov/pubmed/35941265
http://dx.doi.org/10.1038/s41598-022-17071-9

Ejemplares similares